- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02911883
Evaluation of the Repeatability and Reproducibility of AngioVue
June 16, 2017 updated by: Optovue
The purpose of this study is to assess the repeatability and reproducibility of measurements of the vascular structures and the anatomical structures of the posterior pole of the eye based on AngioVue volume scans in normal subjects, glaucoma patients, and retina patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
70
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Seeing eye doctor for routine or follow-up care
Description
Inclusion Criteria:
Normal
- Age > 18.
- No retinal pathology or glaucoma.
Glaucoma patient
- Age > 18.
- Have glaucoma.
Retina patient
- Age > 18.
- Have retina pathology.
Exclusion Criteria:
Normal
- Unable to complete required exams.
- Poor quality image data.
Glaucoma patient
- Unable to complete required exams.
- Poor quality image data.
- Retinal pathology.
Retina patient
- Unable to complete required exams.
- Poor quality image data.
- Glaucoma.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Normal
Not having glaucoma or retinal pathology
|
|
Glaucoma
Having glaucoma.
|
|
Retina
Having retinal pathology
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Retina vasculature
Time Frame: Day 1
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 29, 2016
Primary Completion (Actual)
February 1, 2017
Study Completion (Actual)
February 2, 2017
Study Registration Dates
First Submitted
September 20, 2016
First Submitted That Met QC Criteria
September 21, 2016
First Posted (Estimate)
September 22, 2016
Study Record Updates
Last Update Posted (Actual)
June 20, 2017
Last Update Submitted That Met QC Criteria
June 16, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200-51133
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal, Glaucoma & Retinal Pathology
-
Topcon Medical Systems, Inc.CompletedNormal Eyes | Eyes With Glaucoma | Eyes With Retinal DiseaseUnited States
-
Qlaris Bio, Inc.CompletedNormal Tension Glaucoma (NTG)United States
-
University of North Carolina, Chapel HillSensimed AGCompletedNormal-Tension GlaucomaUnited States
-
Kyorin UniversityCompletedNormal Tension Glaucoma | Macular Retinoschisis | Macular DetachmentJapan
-
Heidelberg Engineering GmbHTerminatedNormal Eyes | Retinal VascularUnited States
-
Heidelberg Engineering GmbHCompletedNormal Eyes | Retinal VascularUnited States
-
Heidelberg Engineering GmbHCompletedNormal Eyes | Retinal VascularUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompletedOpen Angle Glaucoma | Normal Tension GlaucomaBelgium
-
AllerganCompletedGlaucoma, Open-Angle | Normal Tension GlaucomaKorea, Republic of
-
Helsinki University Central HospitalRecruitingNormal Tension GlaucomaFinland
Clinical Trials on Optical Coherence Tomography Angiography
-
Khon Kaen UniversityRecruitingRetinal Vascular | Twin Pregnancy, Antepartum Condition or Complication | Choroidal EffusionThailand
-
Kasr El Aini HospitalCompletedTractional Retinal Detachment | Diabetic Vitreous HemorrhageEgypt
-
Omar SaidCompletedGlaucoma,Primary Open-Angle ,Primary Angle ClosureEgypt
-
University Hospital Inselspital, BerneCompletedRetinal DiseaseSwitzerland
-
Federico II UniversityCompleted
-
Heidelberg Engineering GmbHCompletedNormal Eyes | Retinal VascularUnited States
-
Centre Hospitalier Universitaire, AmiensCompletedAlzheimer Disease | Lewy Body Disease | Retina | Optical Coherence Tomography | Cortical Atrophy | Optical Coherence Tomography Angiography | Retinal Thickening | Retinal Nerve Fibres LayerFrance
-
Sohag UniversityNot yet recruitingChoroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
-
Federico II UniversityCompleted